期刊文献+

Notch1和HES1在骨肉瘤组织中的表达及其对U2OS细胞侵袭能力的影响 被引量:6

Expressions of Notch1 and HES1 in osteosarcoma tissue and their effects on invasion ability of osteosarcoma cell U2OS
下载PDF
导出
摘要 目的:研究Notch1和HES1基因在骨肉瘤组织及骨肉瘤细胞系U2OS中的表达及其对U2OS侵袭能力的影响。方法:组织学水平研究中,配对选取23例骨肉瘤及临近瘤旁正常骨骼肌组织标本;细胞学水平研究中,选取骨肉瘤细胞系U2OS及人正常成骨细胞系h FOB1.19;采用免疫组化法检测组织学水平Notch1及HES1蛋白的表达,采用Western blot及Real-time PCR法检测组织学及细胞学水平Notch1、HES1蛋白及mRNA的表达。用Notch1-siRNA沉默U2OS细胞中Notch1基因后,应用Western blot及Real-time PCR法检测U2OS细胞中Notch1及HES1的表达,Transwell法检测U2OS侵袭能力的变化。结果:相比于正常组织,骨肉瘤组织中Notch1、HES1 mRNA和蛋白呈高表达(t配对=22.567,14.830和8.439,7.100,P<0.001)。U2OS细胞中Notch1、HES1 mRNA和蛋白表达强于h FOB1.19细胞(t=11.053,20.482和28.845,34.681,P<0.001)。沉默Notch1基因后,U2OS细胞Notch1、HES1mRNA和蛋白表达下降(t=6.294,9.209和9.151,13.953,P<0.05),侵袭能力下降(t=71.387,P<0.001)。结论:Notch1和HES1在骨肉瘤组织及骨肉瘤细胞系中呈高表达,沉默Notch1基因可降低U2OS细胞侵袭能力。 Aim:To investigate the expressions of Notch 1 and HES1 gene in osteosarcoma tissue and their effects on invasion ability of osteosarcoma cell U 2OS.Methods:Twenty-three matched tissue specimens of osteosarcoma and matched para-tumor normal tissue, and osteosarcoma cell line U2OS and human osteoblast cell line hFOB1.19 were chosen.The ex-pressions of Notch1 and HES1 mRNA and protein in tissue specimens were detected by immunohistochemistry ,Real-time PCR and Western blot.The expressions of Notch1 and HES1 mRNA and protein in hFOB1.19,U2OS, and U2OS transfect-ed with Notch1-siRNA were detected by Real-time PCR and Western blot , and the cell invasion ability was detected by Tr-answell chambers .Results:Compared with para-tumor normal tissue , the Notch1 and HES1 mRNA and protein expressions in osteosarcoma tissue were higher(tmatch =22.567,14.830 and 8.439,7.100,P〈0.001), and those in U2OS were higher than in hFOB1.19(t=11.053,20.482 and 28.845,34.681,P〈0.001).Compared with U2OS, the Notch1 and HES1 mRNA and protein expressions in U2OS transfected with Notch1-siRNA were lower(t=6.294,9.209 and 9.151,13.953, P〈0.05), and the invasion ability decreased(t=71.387,P〈0.001).Conclusion: Notch1 and HES1 gene show high expression in both tissue and cellular level in osteosarcoma;Notch1 silence can reduce the invasion ability of U 2OS.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2015年第6期777-781,共5页 Journal of Zhengzhou University(Medical Sciences)
基金 国家自然科学基金项目81502333 辽宁省教育厅科学研究一般项目2014418 沈阳市卫生局青年基金项目辽科发[2013]31号 沈阳医学院青年科学基金项目20132041 沈阳医学院科学研究基金项目20151002
关键词 NOTCH1 HES1 骨肉瘤 侵袭 Notch1 HES1 osteosarcoma invasion
  • 相关文献

参考文献22

  • 1Longhi A, Errani C, De Paolis M ,et al. Primary bone osleo- sarcoma in the pediatric age: state of the art [ J ]. Cancer Treat Rev,2006,32(6) :423.
  • 2Wittig JC, Bickels J, Priebat D, et al. Osteosarcoma : a mul- tidisciplinary approach to diagnosis and treatment [ J ]. Am Fam Physician ,2002,65(6) :1123.
  • 3Berman SD,Calo E, I,andman AS,et al. Metastatic osteo- sarcoma induced by inactivation of Rb and p53 in the osle- oblast lineage [ J ]. Proc Natl Acad Sci USA, 2008, 105 (33) :11851.
  • 4Link MP,Goorin AM, Miser AW,et al. The effect of adju- vant chemotherapy on relapse-free survival in patients with osteosareoma of the extremity[ J ]. N Engl J Med,1986,314 ( 25 ) : 1600.
  • 5Allenspach EJ, Maillard I, Aster JC,et al. Notch signaling in cancer[ J ]. Cancer Biol Ther,2002,1 (5) :466.
  • 6Weng AP,Ferrando AA,Lee W,et al. Activating mulations of NOTCH1 in human T cell acute lymphoblastie leukemia [ J ]. Science, 2004,306 ( 5694 ) : 269.
  • 7Bielack SS, Kempf-Bielack B, Delling G, e! al. Prognosticfactors in high-grade osteosarcoma of the extremities or trunk : an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols [ J ]. J Clin Oncol, 2002,20 ( 3 ) : 776.
  • 8Carrie D,Bielack SS. Current strategies of chemotherapy in osteosarcoma [ J ]. Int Orthop ,2006,30 ( 6 ) :445.
  • 9Charafe-Jauffret E, Ginestier C, Iovino F, et al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metas- tasis and poor clinical outcome in inflammatory breast cancer [ J ]. Clin Cancer Res, 20 l 0,16 ( 1 ) :45.
  • 10Meyers PA,Schwartz CL, Krailo MD,et al. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy "im- proves overall survival:a report from the Childreng Oncolo- gy Group [ J ]. J Clin Oncol,2008,26 (4) :633.

同被引文献39

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部